Arcato Reports Phase 1 Results for ARC-001 Gel
Greenville, North Carolina, August 19, 2026 Arcato Laboratories, Inc. has announced positive topline results from its first-in-human Phase 1...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Greenville, North Carolina, August 19, 2026 Arcato Laboratories, Inc. has announced positive topline results from its first-in-human Phase 1...
Jena, Germany, August 19, 2026 ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S....
Coral Gables, Florida, August 18, 2026 Sitero, a global clinical research organization (CRO) and clinical technology company, has announced...
PASADENA, Calif., June 22, 2026 Arrowhead Pharmaceuticals has reached a major regulatory milestone after the European Commission (EC) granted...
LONDON, June 25, 2026 Evaluate, a Norstella company and a leading provider of pharmaceutical market intelligence, has been recognized...
WILMINGTON, Del. & SAN MATEO, Calif., May 20, 2026 Incyte and Genesis Molecular AI have announced a significant expansion...
Las Vegas, Nevada, USA – April 22, 2026 In a landmark move shaping the future of digital transformation in...
Ingelheim, Germany, April 20, 2026 Boehringer Ingelheim has announced a major strategic expansion of its computational innovation capabilities with...
Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...
NEW DELHI, India, March 17, 2026 The National Institute of Pharmaceutical Education and Research (NIPER) Raebareli has signed a...
